Previous 10 | Next 10 |
home / stock / lkysf / lkysf news
The Drug Enforcement Agency ("DEA") is proposing to dramatically increase the legal production of psychedelic drugs to be used for research purposes, Marijuana Moment reports. The agency says in 2022, it is calling for a doubling of psilocybin and psilocyn production, a quadrupling of mescali...
Palm Beach, FL –October 14, 2021 – FinancialNewsMedia.com News Commentary – Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the medical cost of mental health conditions is estimated to ri...
VANCOUVER, BC, Oct. 6, 2021 /PRNewswire/ — Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, ...
Palm Beach, FL – October 5, 2021 – FinancialNewsMedia.com News Commentary – The psychedelic drugs market is creating major potential for treatment of mental illnesses, and as a result, it is likely to see more demand and hence likely to attract major investm...
Acquisition strengthens clinic portfolio for mental health treatment using psychedelic-assisted therapies VANCOUVER, BC, Sept. 23, 2021 /CNW/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental heal...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 9, 2021 – National Suicide Prevention Week is here and it’s not only an opportunity to talk about mental health, but to also look at potential treatments. Suicide re...
VANCOUVER, BC, Sept. 2, 2021 /CNW/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today ...
VANCOUVER, BC, July 29, 2021 /CNW/ - Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)("Numinus" or the "Company"), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its fiscal third-quarter ...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – July 21, 2021 – The early 1970s saw psychedelics and psilocybin products made illegal in the US in the war on drugs. Decades later, new research indicates the medical potential of psiloc...
Real-world study expands access to MDMA-assisted therapy for patients with PTSD and concurrent disorders and will provide data on a regulated model for MDMA-assisted therapy VANCOUVER, BC, July 12, 2021 /CNW/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“...
News, Short Squeeze, Breakout and More Instantly...
Rojo Resources Ltd Company Name:
LKYSF Stock Symbol:
OTCMKTS Market:
--News Direct-- Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com View original content to download multimedia: https://newsdirect.com/news/proactive-research-analyst-on-numinus-wellness-annual-results-434599538
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health advocates are call...
VANCOUVER, BC, Nov. 25, 2021 /PRNewswire/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted thera...